Skip to main content
AR

Advanced Radiotherapy Technologies (ART Health)

Advanced Radiotherapy Technologies (ART Health) partners with hospitals and oncology groups to deliver fully turnkey radiotherapy cancer centers, handling financing, design, construction, equipment procurement, installation, and clinical acceptance. By integrating vendor‑agnostic, cutting‑edge technologies such as biology‑guided radiotherapy, high‑precision radiosurgery, and advanced imaging, ART Health enables partners to expand oncology services quickly without upfront capital or operational burden.

Las Vegas, United StatesFounded 20219100+ followers
Updated 2 months ago

Funding

$30M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

D
Funding rounds are not available yet.

Founders

Product

Problem

Many cancer treatment facilities lack the capital, expertise, and integrated technology needed to build modern radiotherapy centers, resulting in limited patient access to advanced radiation therapies such as biology‑guided radiotherapy, high‑precision radiosurgery, and state‑of‑the‑art imaging.

Solution

Advanced Radiotherapy Technologies (ART Health) partners with hospitals and physician groups to deliver fully turnkey, freestanding radiotherapy centers. ART Health finances, designs, engineers, constructs, installs equipment, and manages clinical acceptance so the partner can begin treating patients without upfront investment or operational burden. The company sources cutting‑edge, vendor‑agnostic technologies—including RefleXion’s SCINTIX biology‑guided system, Varian Edge radiosurgery platform, and Siemens SOMATOM CT simulators—to equip each center with the latest treatment and imaging capabilities. ART Health also provides ongoing facility management, staff training, and marketing support, ensuring a seamless transition from construction to first patient treatment. By handling all development phases, ART Health enables clinical partners to expand their oncology services quickly and cost‑effectively.

Target Audience

Primary customers are hospitals, cancer centers, and physician‑owned oncology practices seeking to add or upgrade radiotherapy capabilities without bearing development risk or capital expense.

Features

  • Full‑service project delivery covering financing, site selection, design, engineering, construction, equipment procurement, installation, and clinical acceptance
  • Vendor‑agnostic technology integration, selecting best‑in‑class equipment such as RefleXion X‑1 SCINTIX, Varian Edge LINAC, and Siemens SOMATOM go.Sim/Go.Open Pro CT simulators
  • Biology‑guided radiotherapy (SCINTIX) that uses tumor‑derived signals for real‑time dose tracking and motion management, reducing planning target volumes and healthy‑tissue exposure
  • High‑precision radiosurgery with sub‑millimeter accuracy, six‑axis treatment couch, and integrated motion‑tracking for fast, non‑invasive intracranial and extracranial treatments
  • AI‑enhanced CT simulation and imaging workflows that automate patient positioning, contouring, and quality control to streamline treatment planning
  • Ongoing operational support including facility management, equipment upgrades, educational programs for staff, and marketing services to drive patient referrals
  • No capital outlay required from the clinical partner; ART Health finances initial operating capital and reserves during the ramp‑up period
This profile is AI-generated and may contain inaccuracies.